Frequency of use and annual costs of biological therapy for psoriasis in Colombia in 2019

Documenti analoghi

• Malignancies in patients with psoriasis during and after biological therapy: A single‐center experience
  di: Hiroyuki Sakai, et al.
  Pubblicazione: (2024)
• Tirzepatide in obese patients with psoriasis on biological therapy: Is this a window of opportunity?
  di: Paolo Gisondi, et al.
  Pubblicazione: (2025)
• Multi‐failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort
  di: Riccardo Viola, et al.
  Pubblicazione: (2024)
• Drug survival of biologics in psoriasis: An Australian multicentre retrospective study
  di: Samantha Ting, et al.
  Pubblicazione: (2024)
• The impacts of biologic treatment on metabolic profiling in psoriasis
  di: Sichun Deng, et al.
  Pubblicazione: (2024)